{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T21:51:21Z","timestamp":1768773081142,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ejpb.2022.08.019","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T01:54:48Z","timestamp":1661997288000},"page":"118-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Development of an ethanol-free salbutamol sulfate metered-dose inhaler: Application of molecular dynamic simulation-based prediction of intermolecular interaction"],"prefix":"10.1016","volume":"179","author":[{"given":"Alaa","family":"Aldabet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somaieh","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salva","family":"Golgoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Haroun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marouf","family":"Alkhayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wassim","family":"Abdelwahed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2022.08.019_b0005","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.2147\/DDDT.S262141","article-title":"The Climate is Changing for Metered-Dose Inhalers and Action is Needed","volume":"14","author":"Pritchard","year":"2020","journal-title":"DDDT"},{"key":"10.1016\/j.ejpb.2022.08.019_b0010","unstructured":"\u201cThe Montreal Protocol on Substances that Deplete the Ozone Layer | Ozone Secretariat.\u201d https:\/\/ozone.unep.org\/treaties\/montreal-protocol (accessed Aug. 06, 2022)."},{"key":"10.1016\/j.ejpb.2022.08.019_b0015","unstructured":"\u201cThe Kigali Amendment (2016): The amendment to the Montreal Protocol agreed by the Twenty-Eighth Meeting of the Parties (Kigali, 10-15 October 2016) | Ozone Secretariat.\u201d https:\/\/ozone.unep.org\/treaties\/montreal-protocol\/amendments\/kigali-amendment-2016-amendment-montreal-protocol-agreed (accessed Aug. 06, 2022)."},{"key":"10.1016\/j.ejpb.2022.08.019_b0020","unstructured":"\u201cCipla seeks price hike for certain respiratory medications, writes to NPPA.\u201d https:\/\/www.moneycontrol.com\/news\/business\/companies\/cipla-seeks-price-hike-for-certain-respiratory-medications-writes-to-nppa-7442041.html (accessed Aug. 06, 2022)."},{"key":"10.1016\/j.ejpb.2022.08.019_b0025","unstructured":"T.S. Purewal, D.J. Greenleaf, \u201cMedicinal aerosol formulations,\u201d US5225183A, Jul. 06, 1993 Accessed: Jul. 31, 2022. [Online]. Available: https:\/\/patents.google.com\/patent\/US5225183A\/en."},{"key":"10.1016\/j.ejpb.2022.08.019_b0030","unstructured":"R. A. Akehurst, A. J. Taylor, and D. A. Wyatt, \u201cAerosol formulations containing P134a and salbutamol,\u201d US5674471A, Oct. 07, 1997 Accessed: Aug. 13, 2022. [Online]. Available: https:\/\/patents.google.com\/patent\/US5674471A\/en?inventor=Rachel+Ann+Akehurst."},{"key":"10.1016\/j.ejpb.2022.08.019_b0035","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0954-6111(00)80143-2","article-title":"Pharmaceutical transition to non-CFC pressurized metered dose inhalers","volume":"94","author":"Cripps","year":"2000","journal-title":"Respir. Med."},{"key":"10.1016\/j.ejpb.2022.08.019_b0040","unstructured":"\u201cOrange Book: Approved Drug Products with Therapeutic Equivalence Evaluations.\u201d https:\/\/www.accessdata.fda.gov\/scripts\/cder\/ob\/index.cfm (accessed Aug. 13, 2022)."},{"issue":"1","key":"10.1016\/j.ejpb.2022.08.019_b0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0378-5173(99)00134-9","article-title":"Drug\u2013surfactant\u2013propellant interactions in HFA-formulations","volume":"186","author":"Vervaet","year":"1999","journal-title":"Int. J. Pharm."},{"issue":"supplement 1","key":"10.1016\/j.ejpb.2022.08.019_b0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/08942680150506303","article-title":"The Influence of Lung Deposition on Clinical Response","volume":"14","author":"Pritchard","year":"2001","journal-title":"J. Aerosol Med."},{"issue":"6","key":"10.1016\/j.ejpb.2022.08.019_b0055","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/j.jaci.2009.09.050","article-title":"Particle size of inhaled corticosteroids: Does it matter?","volume":"124","author":"Leach","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.ejpb.2022.08.019_b0060","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1773-2247(11)50049-8","article-title":"Suspension versus solution metered dose inhalers: different products, different particles?","volume":"21","author":"Jones","year":"2011","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"5","key":"10.1016\/j.ejpb.2022.08.019_b0065","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1208\/s12248-017-0095-3","article-title":"Influence of Formulation Factors on the Aerosol Performance of Suspension and Solution Metered Dose Inhalers: A Systematic Approach","volume":"19","author":"Sheth","year":"2017","journal-title":"AAPS J"},{"issue":"5","key":"10.1016\/j.ejpb.2022.08.019_b0070","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1023\/A:1015825311750","article-title":"Low first-spray drug content in albuterol metered-dose inhalers","volume":"08","author":"Cyr","year":"1991","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.ejpb.2022.08.019_b0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/089426803321919924","article-title":"Balancing Ethanol Cosolvent Concentration with Product Performance in 134a-Based Pressurized Metered Dose Inhalers","volume":"16","author":"Gupta","year":"2003","journal-title":"Journal of Aerosol Medicine"},{"key":"10.1016\/j.ejpb.2022.08.019_b0080","doi-asserted-by":"crossref","unstructured":"S. Soltani, H. Babaei, K. Asadpour Zeynali, A. Jouyban, Modelling Vasorelaxant Activity of Some Drugs\/Drug Candidates Using Artificial Neural Networks, J. Pharmacol. Toxicol. 2(5) (Jun. 2007) 411\u2013426, doi: 10.3923\/jpt.2007.411.426.","DOI":"10.3923\/jpt.2007.411.426"},{"key":"10.1016\/j.ejpb.2022.08.019_b0085","doi-asserted-by":"crossref","unstructured":"S. Soltani, H. Haghaei, A. Shayanfar, J. Vallipour, K. Asadpour Zeynali, A. Jouyban, QSBR Study of Bitter Taste of Peptides: Application of GA-PLS in Combination with MLR, SVM, and ANN Approaches, BioMed Research International, 2013 (2013) 1\u201313, doi: 10.1155\/2013\/501310.","DOI":"10.1155\/2013\/501310"},{"issue":"2","key":"10.1016\/j.ejpb.2022.08.019_b0090","doi-asserted-by":"crossref","first-page":"86","DOI":"10.15171\/PS.2015.22","article-title":"QSAR Analysis of Cyclooxygenase Inhibitors Selectivity Index (COX1\/COX2): Application of SVM-RBF and MLR Methods","volume":"21","author":"Tatardar","year":"2015","journal-title":"Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2022.08.019_b0095","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1590\/S0103-50532008000300032","article-title":"Solubility prediction of solutes in non-aqueous binary solvent mixtures","volume":"19","author":"Jouyban","year":"2008","journal-title":"J. Braz. Chem. Soc."},{"issue":"1","key":"10.1016\/j.ejpb.2022.08.019_b0100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tca.2004.11.002","article-title":"Modeling acid dissociation constant of analytes in binary solvents at various temperatures using Jouyban-Acree model","volume":"428","author":"Jouyban","year":"2005","journal-title":"Thermochim Acta"},{"key":"10.1016\/j.ejpb.2022.08.019_b0105","unstructured":"A. Jouyban, S. Soltani, M. Khoubnasabjafari, W.E. Acree, Refractive index correlation of solvent mixtures at various temperatures, Asian J. Chem., 18(3) (2006) 2037\u20132040, Accessed: Feb. 14, 2022. [Online]. Available: http:\/\/dspace.tbzmed.ac.ir:8080\/xmlui\/handle\/123456789\/51890."},{"issue":"37","key":"10.1016\/j.ejpb.2022.08.019_b0110","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1016\/j.chroma.2011.07.034","article-title":"Modeling the effects of type and concentration of organic modifiers, column type and chemical structure of analytes on the retention in reversed phase liquid chromatography using a single model","volume":"1218","author":"Jouyban","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ejpb.2022.08.019_b0115","unstructured":"A. Jouyban, S. Soltanpour, S. Soltani, H.-K. Chan, W.E. Acree Jr., Solubility prediction of drugs in water-cosolvent mixtures using Abraham solvation parameters, J. Pharm. Pharmaceut Sci. (www.cspscanada.org), vol. 10, no. 3, pp. 263\u2013277, 2007, Accessed: Feb. 14, 2022. [Online]. Available: https:\/\/sites.ualberta.ca\/\u223ccsps\/JPPS10_3\/MS_1168\/MS_1168.html."},{"issue":"3","key":"10.1016\/j.ejpb.2022.08.019_b0120","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.molliq.2009.02.003","article-title":"Prediction of drug solubility in mixed solvents using computed Abraham parameters","volume":"146","author":"Jouyban","year":"2009","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejpb.2022.08.019_b0125","unstructured":"A. Jouyban, S. Soltani, K. Asadpour Zeynali, Solubility prediction of drugs in supercritical carbon dioxide using artificial neural network, Iranian J. Pharm. Res., 6(4) (2007), [Online]. Available: https:\/\/www.sid.ir\/en\/Journal\/ViewPaper.aspx?ID=109303."},{"issue":"2","key":"10.1016\/j.ejpb.2022.08.019_b0130","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1021\/je7005049","article-title":"Naphthalene Solubility in Binary Solvent Mixtures of 2,2,4-Trimethylpentane + Alcohols at 298.15 K","volume":"53","author":"Shayanfar","year":"2008","journal-title":"J. Chem. Eng. Data"},{"issue":"6","key":"10.1016\/j.ejpb.2022.08.019_b0135","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s00044-014-1305-5","article-title":"Developing 2D-QSAR models for naphthyridine derivatives against HIV-1 integrase activity","volume":"24","author":"Zakariazadeh","year":"2015","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejpb.2022.08.019_b0140","doi-asserted-by":"crossref","first-page":"466","DOI":"10.18433\/jpps30611","article-title":"Review of the Cosolvency Models for Predicting Drug Solubility in Solvent Mixtures: An Update","volume":"22","author":"Jouyban","year":"2019","journal-title":"J Pharm Pharm Sci"},{"issue":"6","key":"10.1016\/j.ejpb.2022.08.019_b0145","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/psp4.12413","article-title":"In Silico Methods for Development of Generic Drug-Device Combination Orally Inhaled Drug Products","volume":"8","author":"Walenga","year":"2019","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejpb.2022.08.019_b0150","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/jps.21080","article-title":"Solubility of Solid Solutes in HFA-134a With a Correlation to Physico-Chemical Properties","volume":"97","author":"Hoye","year":"2008","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2022.08.019_b0155","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/jam.2000.13.179","article-title":"An Investigation of the Solubility of Various Compounds in the Hydrofluoroalkane Propellants and Possible Model Liquid Propellants","volume":"13","author":"Dickinson","year":"2000","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.ejpb.2022.08.019_b0160","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.carbpol.2018.11.060","article-title":"Gemcitabine anticancer activity enhancement by water soluble celecoxib\/sulfobutyl ether-\u03b2-cyclodextrin inclusion complex","volume":"206","author":"Rescifina","year":"2019","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.ejpb.2022.08.019_b0165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejpb.2010.12.019","article-title":"Modelling of molecular phase transitions in pharmaceutical inhalation compounds: An in silico approach","volume":"78","author":"Abdel-Halim","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"11","key":"10.1016\/j.ejpb.2022.08.019_b0170","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3390\/polym10111274","article-title":"Molecular Dynamics Simulations of Molecular Diffusion Equilibrium and Breakdown Mechanism of Oil-Impregnated Pressboard with Water Impurity","volume":"10","author":"Guan","year":"2018","journal-title":"Polymers"},{"issue":"4","key":"10.1016\/j.ejpb.2022.08.019_b0175","doi-asserted-by":"crossref","first-page":"126","DOI":"10.11648\/j.ijmsa.20180704.12","article-title":"A Molecular Dynamics Study on the Miscibility of Polyglycolide with Different Polymers","volume":"7","author":"Bichara Abderaman","year":"2018","journal-title":"IJMSA"},{"issue":"1","key":"10.1016\/j.ejpb.2022.08.019_b0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15171\/PS.2017.12","article-title":"An In Vitro Aerosolization Efficiency Comparison of Generic and Branded Salbutamol Metered Dose Inhalers","volume":"23","author":"Rahimkhani","year":"2017","journal-title":"Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ejpb.2022.08.019_b0185","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1208\/s12249-018-1071-7","article-title":"Effects of Formulation Variables on Lung Dosimetry of Albuterol Sulfate Suspension and Beclomethasone Dipropionate Solution Metered Dose Inhalers","volume":"19","author":"Schroeter","year":"2018","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"10.1016\/j.ejpb.2022.08.019_b0190","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/chemse\/bjaa002","article-title":"Lipopolysaccharide-Induced Inflammatory Cytokine Expression in Taste Organoids","volume":"45","author":"Feng","year":"2020","journal-title":"Chem. Senses"},{"issue":"9","key":"10.1016\/j.ejpb.2022.08.019_b0195","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1021\/jp108540n","article-title":"Prediction of Solubility Parameters and Miscibility of Pharmaceutical Compounds by Molecular Dynamics Simulations","volume":"115","author":"Gupta","year":"2011","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejpb.2022.08.019_b0200","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.porgcoat.2016.08.008","article-title":"Polymer-plasticizer compatibility during coating formulation: A multi-scale investigation","volume":"101","author":"Jarray","year":"2016","journal-title":"Prog. Org. Coat."},{"issue":"3","key":"10.1016\/j.ejpb.2022.08.019_b0205","doi-asserted-by":"crossref","first-page":"528","DOI":"10.30574\/wjarr.2021.12.3.0680","article-title":"Theoretical consideration of solubility by Hildebrand solubility approach","volume":"12","author":"Bhamare","year":"2021","journal-title":"World J. Adv. Res. Rev."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122001850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122001850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:49:08Z","timestamp":1760546948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641122001850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":41,"alternative-id":["S0939641122001850"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.08.019","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an ethanol-free salbutamol sulfate metered-dose inhaler: Application of molecular dynamic simulation-based prediction of intermolecular interaction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}